Tell us how we can help
Clinician-to-clinician guidance
Coding, billing and reimbursement questions
Finding my sales representative
Support with an order
More than 100,000 premature infants throughout the world have experienced proven clinical benefits from Prolacta’s 100% human milk–based nutritional products.1
When used as part of an exclusive human milk diet (EHMD) as compared to cow milk–based products, Prolacta’s products have been shown in clinical studies to:
Supplementing mother’s own milk (MOM) with the first commercially available human milk–based fortifier made from 100% human donor milk instead of cow milk
When premature infants need additional calories to support their growth, this human milk–based caloric fortifier delivers
This ready-to-feed, human milk–based product offers NICUs an alternative to cow milk-based formula when MOM is not available
When an adequate supply of MOM is not available, donor milk is rapidly becoming the standard of care for feeding premature infants
Since 2012, the American Academy of Pediatrics (AAP) has recommended human milk for preterm infants, whether MOM or pasteurized donor human milk if MOM is unavailable. For those infants born weighing less than 1500 g, the AAP recommends fortifying MOM or donor human milk with protein and minerals to ensure optimal nutrient intake.13 Our products help hospitals meet the nutritional needs of their medically fragile patients in the NICU.
Hospitals choose Prolacta’s 100% human milk–based nutritional products for the assurance that they are receiving safe, standardized donor milk formulations processed in a pharmaceutical-grade facility under the strictest quality and safety guidelines to protect the health and well-being of their most fragile patients1.
Clinician-to-clinician guidance
Coding, billing and reimbursement questions
Finding my sales representative
Support with an order